Key result
Cystic fibrosis linked to ~2.5-fold higher in-hospital mortality during pulmonary embolism admissions.
Why the study?
Does comorbid cystic fibrosis increase in-hospital mortality and complication rates in patients with pulmonary embolism?
Cohort (n=1,373,084)
Yes
Does comorbid cystic fibrosis increase in-hospital mortality and complication rates in patients with pulmonary embolism?
Cystic fibrosis acts as a severe comorbidity in patients with pulmonary embolism, more than doubling the odds of in-hospital death and significantly increasing the rates of pneumonia and bleeding complications.
Answers are grounded in this paper and cite their sources.
Cystic fibrosis may warrant closer surveillance in pulmonary embolism; leaves open whether targeted strategies improve outcomes.
BACKGROUND: Pulmonary embolism (PE) and cystic fibrosis (CF) are both diseases that impact the cardiovascular-pulmonary system. While CF is a rare heterogeneous monogenetic autosomal-recessive inherited multisystem-disease that reduces life-expectancy, PE is a common emergency event with also high morbidity and mortality. We aimed to investigate the impact of CF on prognosis of PE patients. METHODS: The German nationwide inpatient sample was used for this study. All patient-cases of patients with PE in Germany 2005-2020 were included and stratified for CF. RESULTS: Overall, 1,373,084 patient-cases of PE patients (median age 72.0 years, 53.0 % females) in Germany were included in our study 2005-2020. Among these, 126 patients (0.01 %) were coded with CF. PE patients with CF were younger (33.0 [24.0-43.0] vs. 72.0 [60.0-80.0] years, P < 0.001) displaying a lower prevalence of arterial hypertension, hyperlipidemia and lower comorbidity-burden (Charlson comorbidity index: 2.0 [1.0-4.0] vs. 4.0 [3.0-7.0], P < 0.001) compared to those without CF. In contrast, diabetes mellitus was more frequent in PE patients with CF (49.2 % vs. 18.7 %, P < 0.001). After adjustment for age, sex and comorbidities, CF was associated with higher case-fatality (OR 2.451 [95 % CI 1.542-3.896], P < 0.001), pneumonia (OR 1.518 [95 % CI 1.059-2.176], P = 0.023) and necessity regarding transfusion of blood constituents (OR 3.702 [95 % CI 2.540-5.396], P < 0.001). CONCLUSIONS: PE patients with CF were younger at the time of PE event and accompanied by typical comorbidities such as diabetes mellitus and renal disease compared to PE patients without CF. CF was associated with higher complication rates comprising pneumonia, bleeding events and 2.5-fold increased case-fatality.
No takes yet. Share an insight, caveat, or question.
Keller et al. (2025) conducted a cohort in Pulmonary embolism (n=1,373,084). Cystic fibrosis vs. Absence of cystic fibrosis was evaluated on In-hospital death (adjusted for age, sex, and comorbidities) (OR 2.451, 95% CI 1.542-3.896, p=<0.001). Cystic fibrosis was independently associated with a 2.5-fold higher risk of in-hospital death among patients hospitalized with pulmonary embolism.
Synapse has enriched 10 related papers. Consider them for comparative context: